Chronic paronychia as a manifestation of skin leishmaniasis
Rev. Soc. Bras. Med. Trop; 54 (), 2021
Results: 7
Treatment of tegumentary leishmaniasis in two hemodialysis patients with end-stage renal disease using two series of pentamidine
Rev. Soc. Bras. Med. Trop; 54 (), 2021
Abstract In this study, we present two cases of cutaneous leishmaniasis in patients with end-stage renal disease, who were treated solely with intramuscular pentamidine. In such cases, treatment implies a fine line between therapeutic efficacy and toxicity. This is suggestive of a knowledge gap; however,...
Tegumentary leishmaniasis mimicking visceralization in a cirrhotic patient: atypical cutaneous lesions and local immunological features
Rev. Soc. Bras. Med. Trop; 53 (), 2020
Abstract Tegumentary leishmaniasis (TL) diagnosis is challenging due to the lack of a gold standard diagnostic tool. The diagnosis is significantly harder in regions where visceral leishmaniasis (VL) is also prevalent since immunological tests may present cross-reactivity. A cirrhotic patient from an end...
Neurohistoplasmosis y leishmaniasis cutánea en paciente inmunocompetente
Neurohistoplasmosis and cutaneous leishmaniasis in an immunocompetent patient
Medicina (B.Aires); 79 (4), 2019
La histoplasmosis y la leishmaniasis son enfermedades olvidadas, endémicas en Argentina, y generalmente se asocian a inmunocompromiso. Presentamos el caso de un varón de 16 años, inmunocompetente, con histoplasmosis del sistema nervioso central y leishmaniasis cutánea. Inicialmente, el paciente prese...
Antibacterianos/administración & dosificación, Antifúngicos/administración & dosificación, Infecciones Fúngicas del Sistema Nervioso Central/complicaciones, Infecciones Fúngicas del Sistema Nervioso Central/diagnóstico, Infecciones Fúngicas del Sistema Nervioso Central/tratamiento farmacológico, Histoplasmosis/complicaciones, Histoplasmosis/diagnóstico, Histoplasmosis/tratamiento farmacológico, Inmunocompetencia, Leishmaniasis Cutánea/complicaciones, Leishmaniasis Cutánea/diagnóstico, Leishmaniasis Cutánea/tratamiento farmacológico
American tegumentary leishmaniasis: severe side effects of pentavalent antimonial in a patient with chronic renal failure
An. bras. dermatol; 94 (3), 2019
Abstract: Pentavalent antimonials are the first-line drug treatment for American tegumentary leishmaniasis. We report on a patient with chronic renal failure on hemodialysis who presented with cutaneous lesions of leishmaniasis for four months. The patient was treated with intravenous meglumine under str...
Anfotericina B/uso terapéutico, Antiprotozoarios/efectos adversos, Antiprotozoarios/uso terapéutico, Brasil, Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos, Leishmaniasis Cutánea/complicaciones, Leishmaniasis Cutánea/tratamiento farmacológico, Leishmaniasis Cutánea/patología, Antimoniato de Meglumina/efectos adversos, Diálisis Renal, Insuficiencia Renal Crónica/complicaciones
Clinico-immunological spectrum of American tegumentary leishmaniasis and leprosy coinfection: A case series in Southeastern Brazil
Rev. Soc. Bras. Med. Trop; 52 (), 2019
Abstract INTRODUCTION: American tegumentary leishmaniasis (ATL) and leprosy share common areas of prevalence, but reports of coinfection are scarce. METHODS: We report a series of 9 ATL-leprosy cases and discuss the association. An integrative diagram to analyze the clinico-immunological features of c...